US stock futures flounder amid tech weakness, Fed caution
Klaviyo , Inc. (NASDAQ:NYSE:KVYO), the $9.4 billion market cap technology company, saw Chief People Officer Galvin Carmel sell 11,155 shares of Series A Common Stock on August 18, 2025, for approximately $353,278. The sales were executed at prices ranging from $31.20 to $32.06 per share, near the middle of the stock’s 52-week range of $23.77 to $49.55. According to InvestingPro data, the stock has declined nearly 29% over the past six months.
According to a Form 4 filing with the Securities and Exchange Commission, the transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 26, 2024. Following the sale, Galvin Carmel directly owns 675,833 shares of Series A Common Stock, which includes 86,858 shares and 588,975 unvested restricted stock units (RSUs). InvestingPro analysis reveals the company maintains strong financial health with a current ratio of 4.95 and more cash than debt on its balance sheet.
On August 15, 2025, Galvin Carmel also had 24,817 shares withheld by Klaviyo to cover tax obligations related to the vesting of restricted stock units. The total value of shares withheld was $779,998 at a price of $31.43 per share. For deeper insights into Klaviyo’s valuation and financial metrics, access the comprehensive Pro Research Report available on InvestingPro.
In other recent news, Klaviyo Inc reported impressive second-quarter results, with a notable 32% revenue growth, surpassing Wall Street’s expectations of 26%. This strong performance led the company to raise its fiscal year 2025 growth guidance to 27-28%, an increase of 200 basis points from previous forecasts. In response to these results, Piper Sandler raised its price target for Klaviyo to $55, citing robust international growth of 42% year-over-year. Similarly, TD Cowen and Benchmark adjusted their price targets to $46, both maintaining a Buy rating on the stock.
In addition to these developments, Summit Partners, a significant shareholder in Klaviyo, announced plans to sell 6.5 million shares of Series A common stock in an underwritten public offering. Barclays (LON:BARC), the underwriter, has been granted a 30-day option to purchase an additional 975,000 shares. Klaviyo will not receive any proceeds from this sale. These recent developments reflect ongoing investor interest and activity surrounding the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.